Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
576
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $219M | 0.02% |
8,529,606
+786,961
| +10% | +$15.9M |
|
577
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
| $218M | 0.02% |
3,141,957
+394,815
| +14% | +$25.8M |
|
578
KKR & Co
KKR
$92.3B
| $218M | 0.02% |
7,063,473
-69,110
| -1% | -$1.86M |
|
579
Teledyne Technologies
TDY
$32B
| $218M | 0.02% |
699,644
-76,671
| -10% | -$25.2M |
|
580
Fate Therapeutics
FATE
$326M
| $217M | 0.02% |
6,337,023
-544,660
| -8% | -$16.2M |
|
581
Primerica
PRI
$9.89B
| $217M | 0.02% |
1,863,065
-385,331
| -17% | -$41M |
|
582
Ally Financial
ALLY
$13.3B
| $217M | 0.02% |
10,947,015
+640,956
| +6% | +$10.9M |
|
583
Zscaler
ZS
$27.3B
| $214M | 0.02% |
1,957,321
+318,736
| +19% | +$26.5M |
|
584
AtriCure
ATRC
$2.11B
| $214M | 0.02% |
4,766,815
+1,224,476
| +35% | +$53.3M |
|
585
Itaú Unibanco
ITUB
$87.5B
| $214M | 0.02% |
62,755,644
+11,593,020
| +23% | +$37.6M |
|
586
Agnico Eagle Mines
AEM
$90.5B
| $214M | 0.02% |
3,343,945
+801,403
| +32% | +$47.5M |
|
587
CRH
CRH
$66.8B
| $214M | 0.02% |
6,239,426
-4,697,766
| -43% | -$145M |
|
588
First Horizon
FHN
$12.1B
| $213M | 0.02% |
21,383,355
-6,646,347
| -24% | -$60.4M |
|
589
Cable One
CABO
$212M
| $212M | 0.02% |
119,605
+102,782
| +611% | +$184M |
|
|
IPHI
590
DELISTED
INPHI CORPORATION
IPHI
| $212M | 0.02% |
1,805,584
+1,079,440
| +149% | +$114M |
|
591
Sally Beauty Holdings
SBH
$1.58B
| $212M | 0.02% |
16,930,576
-587,001
| -3% | -$6.42M |
|
592
Booz Allen Hamilton
BAH
$9.15B
| $211M | 0.02% |
2,711,207
-242,214
| -8% | -$18.3M |
|
593
Pfizer
PFE
$153B
| $210M | 0.02% |
6,774,232
-242,858
| -3% | -$8.25M |
|
594
Albemarle
ALB
$15.5B
| $210M | 0.02% |
2,721,995
+629,677
| +30% | +$42.8M |
|
595
Cemex
CX
$16.3B
| $210M | 0.02% |
72,924,249
+29,334,354
| +67% | +$68.8M |
|
596
Deere & Co
DE
$168B
| $209M | 0.02% |
1,332,096
-93,142
| -7% | -$13.5M |
|
597
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $209M | 0.02% |
2,641,542
-94,686
| -3% | -$6.87M |
|
|
DOYU
598
DouYu International Holdings
DOYU
$142M
| $209M | 0.02% |
1,809,139
-74,598
| -4% | -$6.23M |
|
599
Clorox
CLX
$12.7B
| $209M | 0.02% |
951,642
+800,697
| +530% | +$160M |
|
600
HCA Healthcare
HCA
$89.5B
| $209M | 0.02% |
2,148,926
+638,628
| +42% | +$66.4M |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.